Actonis Dual Action 18 Laser Comb (FDA Cleared), 100% Medical-Grade Dual Wavelength Lasers, Hair Growth Device, Red Light Therapy For Hair Growth and Regrowth (Dark Silver)

Regrow thicker, fuller hair and reclaim your confidence with the Actonis 18 Dual Action LaserComb. Engineered for high-performance hair growth stimulation, the Actonis 18 Dual Action LaserComb targets thinning at the source by delivering clinical-grade laser energy directly to the follicles. This advanced hair regrowth treatment utilizes dual wavelengths (655nm and 635nm) to revitalize dormant follicles and support a healthy, natural hair growth cycle. Unlike messy topicals, the Actonis 18 Dual Action LaserComb is a clean, non-invasive laser hair therapy solution that has been clinically studied for the treatment of hereditary hair loss and thinning hair in women. Consistency is key to professional results. With just three easy treatments per week, the Actonis 18 Dual Action LaserComb helps reverse thinning and reduces scalp visibility. Most users experience a visible transformation within 3 to 4 months, as shedding slows and thin, weakened hair is replaced by stronger, more resilient strands. The Actonis 18 Dual Action LaserComb is FDA-indicated for females with Androgenetic Alopecia (Ludwig Classifications I-II) and Fitzpatrick Skin Types I-IV. For optimal safety, always perform a quick 2-minute sensitivity test on the forearm before your first session. Stop settling for thinning hair and start your journey to restored density with the Actonis 18 Dual Action LaserComb.

• Clinical-Grade Hair Regrowth: The Actonis 18 Dual Action LaserComb delivers targeted laser energy to stimulate follicles at the source. This non-invasive laser hair therapy is designed to treat hereditary hair loss and promote thicker, fuller hair growth.
• Dual-Wavelength Technology: Engineered with advanced 655nm and 635nm wavelengths, this device revitalizes dormant hair follicles and supports a natural regrowth cycle, providing a professional-strength alternative to messy topical treatments.
• FDA-Indicated & Clinically Studied: Specifically indicated for females with Androgenetic Alopecia (Ludwig Classifications I-II) and Fitzpatrick Skin Types I-IV. Our technology is clinically studied to ensure safety and efficacy for thinning hair.
• Visible Transformation in 3–4 Months: Achieve professional results with just three easy treatments per week. Most users see a visible reduction in scalp visibility and a decrease in shedding as thin hair is replaced by stronger, more resilient strands.
• Clean & Convenient Design: Say goodbye to greasy serums. The Actonis 18 provides a clean, handheld solution for at-home hair restoration, making it easy to maintain consistency and reclaim your confidence.
• Safety First: Includes a built-in protocol for user safety; a simple 2-minute forearm sensitivity test is recommended prior to the first session to ensure optimal compatibility.